Osaic Holdings’s Histogen Inc. Common Stock HSTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-275
| Closed | -$142 | – | 7642 |
|
|
2023
Q3 | $142 | Hold |
275
| – | – | ﹤0.01% | 7192 |
|
|
2023
Q2 | $196 | Sell |
275
-100
| -27% | -$90 | ﹤0.01% | 7213 |
|
|
2023
Q1 | $454 | Hold |
375
| – | – | ﹤0.01% | 7148 |
|
|
2022
Q4 | $0 | Sell |
375
-5
| -1% | -$6 | ﹤0.01% | 7770 |
|
|
2022
Q3 | $1K | Hold |
380
| – | – | ﹤0.01% | 7187 |
|
|
2022
Q2 | $1K | Hold |
380
| – | – | ﹤0.01% | 7256 |
|
|
2022
Q1 | $2K | Sell |
380
-268
| -41% | -$1.36K | ﹤0.01% | 6968 |
|
|
2021
Q4 | $5K | Buy |
648
+7
| +1% | +$80 | ﹤0.01% | 6711 |
|
|
2021
Q3 | $10K | Buy |
641
+376
| +142% | +$6.36K | ﹤0.01% | 6253 |
|
|
2021
Q2 | $6K | Hold |
265
| – | – | ﹤0.01% | 6333 |
|
|
2021
Q1 | $7K | Buy |
265
+260
| +5,200% | +$6.53K | ﹤0.01% | 6056 |
|
|
2020
Q4 | $0 | Sell |
5
-1
| -17% | -$31 | ﹤0.01% | 6700 |
|
|
2020
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 6525 |
|
|
2020
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 6442 |
|
|
2020
Q1 | $0 | Buy |
+6
| New | +$468 | ﹤0.01% | 6265 |
|
Other funds holding HSTO
Osaic Holdings's HSTO Position: Q4 2023 in Review
Osaic Holdings sold out of Histogen Inc. Common Stock (HSTO) in Q4 2023, closing a stake of 275 shares — an estimated $142 sold.
Osaic Holdings first reported a position in HSTO in Q1 2020 and held it in 15 quarters. The position peaked at $10K in Q3 2021. 1 fund tracked by Wall St. Rank holds HSTO as of Q4 2023.
- Osaic Holdings reported no remaining Histogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Osaic Holdings sold 275 Histogen Inc. Common Stock shares in Q4 2023, an estimated $142.
- Osaic Holdings first reported a position in Histogen Inc. Common Stock in Q1 2020 and held it in 15 quarters.
- Osaic Holdings's Histogen Inc. Common Stock position peaked at $10K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2023.
Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.